CAH
43
2
PH
74
4
MPC
54
2
HD
31
3
HCA
42
3
NAVI
44
11
NOV
62
2
PRGO
53
3
COP
62
2
GRMN
61
2
ZTS
25
5
DHR
52
11
PPL
57
-2
TSCO
48
2
MAC
71
4
VIX
49
-12
DIS
72
3
PEG
48
-2
AVGO
40
10
COST
63
3
CAH
43
2
PH
74
4
MPC
54
2
HD
31
3
HCA
42
3
NAVI
44
11
NOV
62
2
PRGO
53
3
COP
62
2
GRMN
61
2
ZTS
25
5
DHR
52
11
PPL
57
-2
TSCO
48
2
MAC
71
4
VIX
49
-12
DIS
72
3
PEG
48
-2
AVGO
40
10
COST
63
3
Financhill
Back

Cytokinetics Stock Price Chart

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Sell
39

CYTK
Cytokinetics

Last Price:
66.00
Seasonality Move:
9.34%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 67.87 Sell
20-day SMA: 70.47 Sell
50-day SMA: 70.8 Sell
200-day SMA: 50.8 Buy
8-day EMA: 67.85 Sell
20-day EMA: 69.24 Sell
50-day EMA: 69.78 Sell
200-day EMA: 57.15 Buy

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 39 Sell
Chaikin Money Flow: -1251323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.09 - 72.63) Sell
Bollinger Bands (100): (50.98 - 86.16) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 65.57 while CYTK 8-day simple moving average is 67.87, which is a Sell signal.
  • The stock price of CYTK is 65.57 while Cytokinetics 20-day SMA is 70.47, which makes it a Sell.
  • Cytokinetics 50-day simple moving average is 70.80 while CYTK share price is 65.57, making it a Sell technically.
  • CYTK stock price is 65.57 and Cytokinetics 200-day simple moving average is 50.80, creating a Buy signal.

CYTK Technical Analysis vs Fundamental Analysis

Sell
39
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Sell
    The current Cytokinetics [CYTK] share price is $65.57. The Score for CYTK is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.

Cytokinetics Stock Info

Market Cap:
6.75B
Price in USD:
65.57
Share Volume:
1.28M

Cytokinetics 52-Week Range

52-Week High:
110.25
52-Week Low:
25.98
Sell
39
Cytokinetics (CYTK) is a Sell

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 65.57 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 65.57 while CYTK 8-day exponential moving average is 67.85, which is a Sell signal.
  • The stock price of CYTK is 65.57 while Cytokinetics 20-day EMA is 69.24, which makes it a Sell.
  • Cytokinetics 50-day exponential moving average is 69.78 while CYTK share price is 65.57, making it a Sell technically.
  • CYTK stock price is 65.57 and Cytokinetics 200-day simple moving average is 57.15, creating a Buy signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.